BRAF and neoplasm: The G469A mutation has been reported to have no enhancing effect on BRAF (Smalley and Flaherty, 2009) but it has been reported that kinase-dead BRAF mutations of D594 can have an indirect effect on tumor progression by enhancing CRAF activity (Heidorn et al., 2010).